US4359465A
(en)
*
|
1980-07-28 |
1982-11-16 |
The Upjohn Company |
Methods for treating gastrointestinal inflammation
|
CH644116A5
(de)
*
|
1980-08-21 |
1984-07-13 |
Hoffmann La Roche |
Imidazolderivate.
|
ZA825106B
(en)
*
|
1981-08-13 |
1983-04-27 |
Haessle Ab |
Novel pharmaceutical compositions
|
KR840002371A
(ko)
*
|
1981-11-05 |
1984-06-25 |
귄터 미카엘, 헤르페르트 수키 |
치환된 벤즈 이미다졸의 제조방법
|
US4472409A
(en)
*
|
1981-11-05 |
1984-09-18 |
Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung |
2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
|
DE3216843C2
(de)
*
|
1982-05-05 |
1986-10-23 |
Ludwig Heumann & Co GmbH, 8500 Nürnberg |
3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
SE8204879D0
(sv)
*
|
1982-08-26 |
1982-08-26 |
Haessle Ab |
Novel chemical intermediates
|
SE8300736D0
(sv)
*
|
1983-02-11 |
1983-02-11 |
Haessle Ab |
Novel pharmacologically active compounds
|
SE8301182D0
(sv)
*
|
1983-03-04 |
1983-03-04 |
Haessle Ab |
Novel compounds
|
IL71664A
(en)
*
|
1983-05-03 |
1987-11-30 |
Byk Gulden Lomberg Chem Fab |
Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
|
HU193408B
(en)
*
|
1983-05-03 |
1987-10-28 |
Byk Gulden Lomberg Chem Fqb |
Process for production of new tree-cycle compounds
|
US5077407A
(en)
*
|
1983-07-01 |
1991-12-31 |
The Upjohn Company |
Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-) pyridylalkylenesulfinyl]benzimidazoles
|
CA1259070A
(fr)
*
|
1983-07-01 |
1989-09-05 |
Upjohn Company (The) |
Derives de substitution de 2-¬noyaux condenses (3,4- 4,5-, 5,6-)-pyridylalcoylenesulfinyl|- benzimidazoles
|
DE3333314A1
(de)
*
|
1983-09-15 |
1985-03-28 |
Hoechst Ag, 6230 Frankfurt |
Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
|
US4663347A
(en)
|
1983-10-31 |
1987-05-05 |
Merck Frosst Canada, Inc. |
Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
|
US4575554A
(en)
*
|
1983-12-05 |
1986-03-11 |
The Upjohn Company |
Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
|
ZW4585A1
(en)
*
|
1984-04-19 |
1985-11-20 |
Hoffmann La Roche |
Imidazole derivatives
|
SE8403179D0
(sv)
*
|
1984-06-13 |
1984-06-13 |
Haessle Ab |
New compounds
|
IL75400A
(en)
*
|
1984-06-16 |
1988-10-31 |
Byk Gulden Lomberg Chem Fab |
Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
|
DE3585252D1
(de)
|
1984-07-06 |
1992-03-05 |
Fisons Plc |
Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
|
SE8404065D0
(sv)
*
|
1984-08-10 |
1984-08-10 |
Haessle Ab |
Novel biologically active compounds
|
JPS6150978A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
JPS6150979A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
US4619997A
(en)
*
|
1984-09-06 |
1986-10-28 |
The Upjohn Company |
Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
|
KR890000387B1
(ko)
*
|
1984-09-24 |
1989-03-16 |
디 엎존 캄파니 |
2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
|
SE8405588D0
(sv)
*
|
1984-11-08 |
1984-11-08 |
Haessle Ab |
New compounds
|
EP0187977B1
(fr)
*
|
1984-12-18 |
1990-08-29 |
Otsuka Pharmaceutical Co., Ltd. |
Dérivés de tétrahydroquinoline, leur procédé de préparation et compositions anti-ulcère gastrique les contenant
|
FI861772A
(fi)
*
|
1985-05-07 |
1986-11-08 |
Chemie Linz Ag |
Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
|
AU5768886A
(en)
|
1985-05-24 |
1986-11-27 |
G.D. Searle & Co. |
2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
|
US5869513A
(en)
*
|
1985-05-24 |
1999-02-09 |
G. D. Searle & Co. |
2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
|
CA1309557C
(fr)
|
1985-06-18 |
1992-10-27 |
Robert N. Young |
Antagonistes de leucotrienes
|
US4738975A
(en)
*
|
1985-07-02 |
1988-04-19 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, and use as anti-ulcer agents
|
AR243167A1
(es)
|
1985-08-24 |
1993-07-30 |
Hoechst Ag |
Procedimiento para la preparacion de toluidinas sustituidas.
|
JPS6261978A
(ja)
*
|
1985-09-12 |
1987-03-18 |
Otsuka Pharmaceut Co Ltd |
5−フルオロ−1h−ベンズイミダゾ−ル誘導体
|
SE8505112D0
(sv)
*
|
1985-10-29 |
1985-10-29 |
Haessle Ab |
Novel pharmacological compounds
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US6749864B2
(en)
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
CA1327010C
(fr)
*
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production
|
EP0234485B1
(fr)
*
|
1986-02-20 |
1992-04-01 |
Hoechst Aktiengesellschaft |
Dérivés substitués du thiénoimidazole, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur application comme inhibiteurs de la sécrétion du suc gastrique
|
WO1987005296A1
(fr)
*
|
1986-03-07 |
1987-09-11 |
Pfizer Inc. |
2-[(2-pyridyl)methylsulfinyl]thienoimidazoles et composes apparentes utilises en tant qu'agents de traitement ou de prevention des ulceres
|
DE3786030T2
(de)
|
1986-03-27 |
1993-12-02 |
Merck Frosst Canada Inc |
Tetrahydrocarbazole Ester.
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
GB2189699A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
US4772619A
(en)
*
|
1986-07-17 |
1988-09-20 |
G. D. Searle & Co. |
[(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
|
US4687775A
(en)
*
|
1986-07-17 |
1987-08-18 |
G. D. Searle & Co. |
2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
|
US4721718A
(en)
*
|
1986-08-18 |
1988-01-26 |
G. D. Searle & Co. |
2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
|
CA1256109A
(fr)
*
|
1986-09-10 |
1989-06-20 |
Franz Rovenszky |
Methode de preparation de derives de 4,5-dihydro- oxazoles
|
SE8604566D0
(sv)
*
|
1986-10-27 |
1986-10-27 |
Haessle Ab |
Novel compunds
|
FI90544C
(fi)
*
|
1986-11-13 |
1994-02-25 |
Eisai Co Ltd |
Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
|
ATE103912T1
(de)
*
|
1986-11-13 |
1994-04-15 |
Eisai Co Ltd |
Pyridin-derivate, deren pharmazeutische zusammenstellungen, deren anwendung fuer die herstellung von arzneimitteln mit therapeutischem oder vorbeugendem wert und verfahren zu deren herstellung.
|
NZ234564A
(en)
|
1986-11-21 |
1991-04-26 |
Haessle Ab |
1-substituted benzimidazoles and pharmaceutical compositions
|
SE8604998D0
(sv)
|
1986-11-21 |
1986-11-21 |
Haessle Ab |
Novel pharmacological compounds
|
DE3639926A1
(de)
*
|
1986-11-22 |
1988-06-01 |
Hoechst Ag |
Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
|
FI91754C
(fi)
*
|
1986-12-02 |
1994-08-10 |
Tanabe Seiyaku Co |
Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
|
JPS63230633A
(ja)
*
|
1987-03-19 |
1988-09-27 |
Nippon Chemiphar Co Ltd |
胃腸の細胞保護剤
|
DE3719783A1
(de)
*
|
1987-06-13 |
1988-12-22 |
Hoechst Ag |
Verfahren zur herstellung von 5-phenylsulfinyl-1h-2-(methoxycarbonylamino)- benzimidazol
|
JP2718945B2
(ja)
*
|
1987-06-17 |
1998-02-25 |
エーザイ株式会社 |
ピリジン誘導体及びそれを含有する潰瘍治療剤
|
FI96860C
(fi)
*
|
1987-06-17 |
1996-09-10 |
Eisai Co Ltd |
Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
|
DE3723327A1
(de)
*
|
1987-07-15 |
1989-02-02 |
Hoechst Ag |
Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
|
DK171989B1
(da)
*
|
1987-08-04 |
1997-09-08 |
Takeda Chemical Industries Ltd |
Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
|
EP0425505B1
(fr)
*
|
1988-06-30 |
1993-03-17 |
The Upjohn Company |
Agents anti-secretoires transdermiques pour troubles gastro-intestinaux
|
US5223515A
(en)
*
|
1988-08-18 |
1993-06-29 |
Takeda Chemical Industries, Ltd. |
Injectable solution containing a pyridyl methylsulfinylbenzimidazole
|
WO1990002124A1
(fr)
*
|
1988-08-23 |
1990-03-08 |
Aktiebolaget Hässle |
Traitement du glaucome et des troubles associes de l'×il chez l'homme au moyen de (sulfinyle ou thio)benzimidazoles de pyridinylmethyle
|
US5075323A
(en)
*
|
1988-08-24 |
1991-12-24 |
Aktiebolaget Hassle |
Compounds including omeprazole in the treatment of glaucoma
|
US5175286A
(en)
*
|
1988-09-20 |
1992-12-29 |
Hisamitsu Pharmaceutical Co., Inc. |
Dibenz[b,e]oxepin derivatives
|
AT391693B
(de)
*
|
1988-11-15 |
1990-11-12 |
Cl Pharma |
Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
|
EG19302A
(en)
*
|
1988-12-22 |
1994-11-30 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
SE8804628D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New compounds
|
SE8804629D0
(sv)
*
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
JP2694361B2
(ja)
*
|
1989-02-09 |
1997-12-24 |
アストラ アクチエボラグ |
抗菌剤
|
GB2239453A
(en)
*
|
1989-11-27 |
1991-07-03 |
Haessle Ab |
Omeprazole
|
US5049674A
(en)
*
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US5274099A
(en)
*
|
1989-12-20 |
1993-12-28 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
KR930000861B1
(ko)
*
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
오메프라졸 직장투여 조성물
|
KR100206150B1
(ko)
|
1990-04-04 |
1999-07-01 |
로버트 피. 블랙버언 |
항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체
|
SE9002043D0
(sv)
*
|
1990-06-07 |
1990-06-07 |
Astra Ab |
Improved method for synthesis
|
SE9002206D0
(sv)
|
1990-06-20 |
1990-06-20 |
Haessle Ab |
New compounds
|
HUT62882A
(en)
*
|
1990-06-20 |
1993-06-28 |
Astra Ab |
Process for producing dialkoxy pyridylmethyl sulfinyl benzimidazole derivatives and pharmaceutical compositions comprising same
|
US5061805A
(en)
*
|
1990-08-10 |
1991-10-29 |
Reilly Industries, Inc. |
Process for preparing 2-methyl-3,5-dialkylpyridines by dealkylation with sulfur
|
CA2052698A1
(fr)
*
|
1990-10-11 |
1992-04-12 |
Roger G. Berlin |
Traitement des ulceres peptiques
|
EP0480716A1
(fr)
|
1990-10-12 |
1992-04-15 |
Merck Frosst Canada Inc. |
Acides hydroxyalkylquinoliniques saturés comme antagonistes de leukotriène
|
EP0481764B1
(fr)
|
1990-10-17 |
2000-03-29 |
Takeda Chemical Industries, Ltd. |
Dérivés de pyridine, leur préparation et utilisation
|
ES2026761A6
(es)
*
|
1990-10-31 |
1992-05-01 |
Genesis Para La Investigacion |
Procedimiento de obtencion del omeprazol.
|
NZ244301A
(en)
*
|
1991-09-20 |
1994-08-26 |
Merck & Co Inc |
Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
|
FR2692146B1
(fr)
*
|
1992-06-16 |
1995-06-02 |
Ethypharm Sa |
Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
|
KR0144793B1
(ko)
*
|
1992-07-08 |
1998-07-15 |
제임스 클리프튼 보올딩 |
돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸
|
WO1994002141A1
(fr)
*
|
1992-07-28 |
1994-02-03 |
Astra Aktiebolag |
Injection et trousse d'injection contenant de l'omeprazole et ses analogues
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE9302396D0
(sv)
*
|
1993-07-09 |
1993-07-09 |
Ab Astra |
A novel compound form
|
SE9302395D0
(sv)
*
|
1993-07-09 |
1993-07-09 |
Ab Astra |
New pharmaceutical formulation
|
US5410054A
(en)
*
|
1993-07-20 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
|
TW280770B
(fr)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
KR960705811A
(ko)
*
|
1993-10-29 |
1996-11-08 |
고오야 다다시 |
피리딘 화합물 및 그의 약학적 용도[pyridine compound and medicinal use thereof]
|
US5374730A
(en)
*
|
1993-11-04 |
1994-12-20 |
Torcan Chemical Ltd. |
Preparation of omeprazole and lansoprazole
|
US5502195A
(en)
*
|
1993-11-04 |
1996-03-26 |
Slemon; Clarke |
Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole
|
KR0142815B1
(ko)
*
|
1994-12-02 |
1998-07-15 |
정도언 |
신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
|
KR0179401B1
(ko)
*
|
1994-02-28 |
1999-03-20 |
송택선 |
신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
|
WO1995029897A1
(fr)
*
|
1994-04-29 |
1995-11-09 |
G.D. Searle & Co. |
Procede d'utilisation d'inhibiteurs de (h+/k+)atpase comme agents antiviraux
|
CZ289804B6
(cs)
|
1994-07-08 |
2002-04-17 |
Astrazeneca Ab |
Multijednotková tabletovaná dávková forma I
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
GB9423970D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Oxidation
|
GB9423968D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Resolution
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
JP3015702B2
(ja)
*
|
1995-02-21 |
2000-03-06 |
株式会社アラクス |
イミダゾール誘導体及びそれらの薬剤として許容される酸付加塩及びその製造法並びにそれらを有効成分とする抗潰瘍剤
|
JP3046924B2
(ja)
*
|
1995-03-27 |
2000-05-29 |
株式会社アラクス |
イミダゾリン誘導体又はそれらの可能な互変異性体及びそれらの製造方法並びにそれらを有効成分とする創傷治療薬
|
US5708017A
(en)
*
|
1995-04-04 |
1998-01-13 |
Merck & Co., Inc. |
Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US5686588A
(en)
*
|
1995-08-16 |
1997-11-11 |
Yoo; Seo Hong |
Amine acid salt compounds and process for the production thereof
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
DK1308159T3
(da)
*
|
1995-09-21 |
2005-02-14 |
Pharma Pass Ii Llc |
Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf
|
SE521100C2
(sv)
*
|
1995-12-15 |
2003-09-30 |
Astra Ab |
Förfarande för framställning av en bensimidazolförening
|
KR970032861A
(ko)
*
|
1995-12-29 |
1997-07-22 |
김준웅 |
헬리코박터 피로리 제거용 약제 투여방법
|
US20050054682A1
(en)
*
|
1996-01-04 |
2005-03-10 |
Phillips Jeffrey O. |
Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
*
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
WO1997029103A2
(fr)
*
|
1996-02-06 |
1997-08-14 |
Pdi-Research Laboratories, Inc. |
Synthese de derives de la pyridine du type omeprazole et intermediaires correspondants
|
US6623759B2
(en)
*
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
US5625069A
(en)
*
|
1996-07-22 |
1997-04-29 |
Development Center For Biotechnology |
Process for preparing 2-cyano-3,5-dimethyl-4-methoxypyridine
|
US6380222B2
(en)
|
1996-10-11 |
2002-04-30 |
Astrazeneca Ab |
Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
|
TW385306B
(en)
*
|
1996-11-14 |
2000-03-21 |
Takeda Chemical Industries Ltd |
Method for producing crystals of benzimidazole derivatives
|
SE510666C2
(sv)
*
|
1996-12-20 |
1999-06-14 |
Astra Ab |
Nya Kristallmodifikationer
|
CA2204580A1
(fr)
*
|
1997-05-06 |
1998-11-06 |
Michel Zoghbi |
Synthese de derives de la pyridine utiles en pharmacie
|
US6437139B1
(en)
|
1997-05-06 |
2002-08-20 |
Pdi-Research Laboratories, Inc. |
Synthesis of pharmaceutically useful pyridine derivatives
|
KR100463031B1
(ko)
*
|
1997-05-26 |
2005-04-06 |
동아제약주식회사 |
5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
|
SE9702000D0
(sv)
*
|
1997-05-28 |
1997-05-28 |
Astra Ab |
New pharmaceutical formulation
|
EP0983263A1
(fr)
*
|
1997-05-30 |
2000-03-08 |
Dr. Reddy's Research Foundation |
Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
SE510643C2
(sv)
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
DE69814862T2
(de)
*
|
1997-07-11 |
2004-02-19 |
Eisai Co., Ltd. |
Verfahren zur herstellung von pyridinderivaten
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
WO1999004816A1
(fr)
|
1997-07-25 |
1999-02-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Inhibiteur de la pompe a protons en combinaison therapeutique avec des substances antibacteriennes
|
US6296876B1
(en)
|
1997-10-06 |
2001-10-02 |
Isa Odidi |
Pharmaceutical formulations for acid labile substances
|
US7230014B1
(en)
|
1997-10-14 |
2007-06-12 |
Eisai Co., Ltd. |
Pharmaceutical formulation comprising glycine as a stabilizer
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9704183D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New process
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
DE19754324A1
(de)
*
|
1997-12-08 |
1999-06-10 |
Byk Gulden Lomberg Chem Fab |
Neue Darreichungsform enthaltend einen säurelabilen Wirkstoff
|
AU751066B2
(en)
|
1997-12-08 |
2002-08-08 |
Nycomed Gmbh |
Novel administration form comprising an acid-labile active compound
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
US6159968A
(en)
*
|
1998-01-15 |
2000-12-12 |
University Of Cincinnati |
Activation of chloride channels for correction of defective chloride transport
|
KR100396431B1
(ko)
*
|
1998-01-26 |
2003-09-02 |
가부시키가이샤 구라레 |
2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이
|
US6350876B2
(en)
|
1998-01-26 |
2002-02-26 |
Kuraray Co., Ltd. |
4-chloro-3,5-dimethyl-2-sulfonyl pyridines
|
IT1299198B1
(it)
|
1998-03-05 |
2000-02-29 |
Nicox Sa |
Sali nitrati di farmaci antiulcera
|
CA2323680C
(fr)
|
1998-05-18 |
2007-05-22 |
Takeda Chemical Industries, Ltd. |
Comprimes se desintegrant dans la bouche
|
US6303787B1
(en)
|
1998-05-27 |
2001-10-16 |
Natco Pharma Limited |
Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
WO2000000474A1
(fr)
*
|
1998-06-26 |
2000-01-06 |
Russinsky Limited |
Blocs constitutifs de pyrimidine utilises comme intermediaires dans la synthese de composes pharmaceutiquement actifs
|
SI20019A
(sl)
|
1998-07-13 |
2000-02-29 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
YU10101A
(sh)
*
|
1998-08-10 |
2003-10-31 |
Partnership Of Michael E. Garst George Sachs And Jai Moo Shin |
Prolekovi inhibitori proton pumpe
|
US6166213A
(en)
*
|
1998-08-11 |
2000-12-26 |
Merck & Co., Inc. |
Omeprazole process and compositions thereof
|
US6191148B1
(en)
*
|
1998-08-11 |
2001-02-20 |
Merck & Co., Inc. |
Omerazole process and compositions thereof
|
PT1105105E
(pt)
|
1998-08-12 |
2006-07-31 |
Altana Pharma Ag |
Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
US6733778B1
(en)
*
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9803772D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
WO2000027841A1
(fr)
*
|
1998-11-06 |
2000-05-18 |
Dong-A Pharmaceutical Co., Ltd. |
Procede de preparation de derives de sulfure
|
UA72748C2
(en)
*
|
1998-11-10 |
2005-04-15 |
Astrazeneca Ab |
A novel crystalline form of omeprazole
|
IL142703A
(en)
*
|
1998-11-10 |
2006-04-10 |
Astrazeneca Ab |
Crystalline form of omeprazole
|
JP3926936B2
(ja)
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
DE60021570T2
(de)
|
1999-06-07 |
2006-05-24 |
Altana Pharma Ag |
Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor
|
IL130602A0
(en)
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
AU777667B2
(en)
*
|
1999-08-26 |
2004-10-28 |
Aaipharma Incorporated |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6262085B1
(en)
*
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
EP1206263A1
(fr)
*
|
1999-08-26 |
2002-05-22 |
aaiPharma Inc. |
Mesure spectroscopique raman par transformee de fourier du rapport isomerique de l'omeprazole dans une composition
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
EP1595879A3
(fr)
*
|
1999-08-26 |
2010-01-27 |
aaiPharma Inc. |
Composés de benzimidazole substitués par un alkoxy, préparations pharmaceutiques contenant ces derniers, et procédés d'utilisation
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6228400B1
(en)
|
1999-09-28 |
2001-05-08 |
Carlsbad Technology, Inc. |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
DE19951960C2
(de)
*
|
1999-10-28 |
2002-06-27 |
Gruenenthal Gmbh |
Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
|
CA2290893C
(fr)
|
1999-11-16 |
2007-05-01 |
Bernard Charles Sherman |
Omeprazole de magnesium
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
EP1248790A1
(fr)
*
|
1999-12-17 |
2002-10-16 |
Ariad Pharmaceuticals, Inc. |
Inhibiteurs de la pompe a protons
|
US6787342B2
(en)
|
2000-02-16 |
2004-09-07 |
Merial Limited |
Paste formulations
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
SE0000774D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
SE0002476D0
(sv)
|
2000-06-30 |
2000-06-30 |
Astrazeneca Ab |
New compounds
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
WO2002026210A2
(fr)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Formulation d'inhibiteur de la pompe à protons
|
BR0115989A
(pt)
|
2000-12-07 |
2004-01-13 |
Altana Pharma Ag |
Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
|
DK1341528T3
(da)
|
2000-12-07 |
2012-03-26 |
Nycomed Gmbh |
Hurtigtopløsende tablet omfattende en syrelabil aktiv bestanddel
|
US7988999B2
(en)
|
2000-12-07 |
2011-08-02 |
Nycomed Gmbh |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
|
YU61103A
(sh)
|
2001-02-02 |
2006-05-25 |
Teva Pharmaceutical Industries Ltd. |
Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
|
US6645946B1
(en)
|
2001-03-27 |
2003-11-11 |
Pro-Pharmaceuticals, Inc. |
Delivery of a therapeutic agent in a formulation for reduced toxicity
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
SI20875A
(sl)
*
|
2001-04-25 |
2002-10-31 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Kristalna oblika omeprazola
|
EP1411900B2
(fr)
*
|
2001-06-01 |
2013-12-04 |
Pozen, Inc. |
Compositions pharmaceutiques destinees a la liberation coordonnee d'ains
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
DE10140492A1
(de)
|
2001-08-17 |
2003-08-14 |
Gruenenthal Gmbh |
Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
CN1243749C
(zh)
*
|
2001-09-18 |
2006-03-01 |
泽里新药工业株式会社 |
苯并咪唑衍生物
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
PT1459737E
(pt)
|
2001-10-17 |
2012-11-26 |
Takeda Pharmaceutical |
Grânulos contendo um composto químico instável em meio ácido em concentração elevada
|
US7855082B1
(en)
|
2001-10-31 |
2010-12-21 |
Astrazeneca Ab |
Raman spectroscopic method for determining the ratio of 5-methoxy and 6-methoxy isomers of omeprazole
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
WO2003074514A1
(fr)
|
2002-03-05 |
2003-09-12 |
Astrazeneca Ab |
Sels d'alkylammonium d'omeprazole et d'esomeprazole
|
EP1492511B3
(fr)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
|
CN100577164C
(zh)
|
2002-04-09 |
2010-01-06 |
弗拉梅技术公司 |
可改进释放阿莫西林的微囊含水混悬液形式的口服药物制剂
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
US20040034078A1
(en)
*
|
2002-06-14 |
2004-02-19 |
Agouron Pharmaceuticals, Inc. |
Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase
|
MXPA05000657A
(es)
*
|
2002-07-19 |
2005-08-19 |
Winston Pharmaceuticals Llc |
Profarmacos de los inhibidores de bomba de protones.
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
AU2003254282A1
(en)
*
|
2002-08-01 |
2004-02-23 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
AU2003273000A1
(en)
|
2002-10-16 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
SE0203092D0
(en)
*
|
2002-10-18 |
2002-10-18 |
Astrazeneca Ab |
Method for the synthesis of a benzimidazole compound
|
FR2845915B1
(fr)
|
2002-10-21 |
2006-06-23 |
Negma Gild |
Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
|
AU2003278406A1
(en)
*
|
2002-10-22 |
2004-05-13 |
Ranbaxy Laboratories Limited |
Amorphous form of esomeprazole salts
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
CA2507889C
(fr)
|
2002-12-06 |
2012-02-07 |
Altana Pharma Ag |
Procede de preparation de (s)-pantoprazole
|
PL375818A1
(en)
|
2002-12-06 |
2005-12-12 |
Altana Pharma Ag |
Process for preparing optically pure active compounds
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
CA2510849A1
(fr)
*
|
2002-12-19 |
2004-07-08 |
Teva Pharmaceutical Industries Ltd |
Etats solides de sodium de pantoprazole, leurs procedes de preparation et procedes de preparation d'hydrates de sodium de pantoprazole connus
|
WO2004066924A2
(fr)
*
|
2003-01-24 |
2004-08-12 |
Andrx Labs Llc |
Nouvelle formulation pharmaceutique contenant un inhibiteur de pompe a proton et un antiacide
|
EP1603537A4
(fr)
*
|
2003-02-20 |
2009-11-04 |
Santarus Inc |
Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique
|
US20040185119A1
(en)
*
|
2003-02-26 |
2004-09-23 |
Theuer Richard C. |
Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
|
EP1601667A2
(fr)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Formes solides cristallines et amorphes de pantoprazole et procedes de preparation de ces formes
|
JP4355703B2
(ja)
*
|
2003-03-13 |
2009-11-04 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
歯ぎしりの予防剤または治療剤
|
US20040185092A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Yih Ming Hsiao |
Pharmaceutical preparations of omeprazole and/or clarithromycin for oral use
|
FR2852956B1
(fr)
*
|
2003-03-28 |
2006-08-04 |
Negma Gild |
Procede de preparation enantioselective de derives de sulfoxydes
|
WO2004087702A2
(fr)
*
|
2003-03-28 |
2004-10-14 |
Sidem Pharma |
Procede de preparation enantioselective de derives de sulfoxydes.
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US7524837B2
(en)
*
|
2003-05-12 |
2009-04-28 |
Janssen Pharmaceutica N.V. |
Benzotriazapinone salts and methods for using same
|
EP1615913A2
(fr)
*
|
2003-06-10 |
2006-01-18 |
Teva Pharmaceutical Industries Limited |
Procede de preparation de benzimidazoles 2- (pyridinyl)methyl]sulfinyle substitues et nouveau derives chlorures de pantoprazole
|
CA2529984C
(fr)
*
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
|
WO2005016917A1
(fr)
*
|
2003-07-15 |
2005-02-24 |
Allergan, Inc. |
Procede de preparation de promedicaments isomeriquement purs d'inhibiteurs de la pompe a protons
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP2006528182A
(ja)
*
|
2003-07-18 |
2006-12-14 |
サンタラス インコーポレイティッド |
薬学的製剤および酸に起因する消化器疾患の治療法
|
AR045062A1
(es)
*
|
2003-07-18 |
2005-10-12 |
Santarus Inc |
Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
|
JP2007504261A
(ja)
*
|
2003-09-03 |
2007-03-01 |
エイジーアイ・セラピューティクス・リサーチ・リミテッド |
プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
WO2005039640A1
(fr)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions contenant des peptides en trefle et/ou des mucoadhesifs et des promedicaments d'un inhibiteur de pompe a proton
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
WO2005040816A1
(fr)
*
|
2003-10-24 |
2005-05-06 |
Immunaid Pty Ltd |
Methode therapeutique
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
EP1716136A1
(fr)
|
2004-02-11 |
2006-11-02 |
Ulkar Kimya Sanayii Ve Ticaret A.S. |
Pyridine benzimidazole sulphoxides de grande pureté
|
AU2005216862A1
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Compositions comprising prodrugs of proton pump inhibitors
|
US20070161679A1
(en)
*
|
2004-02-18 |
2007-07-12 |
Allergan, Inc. |
Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
SE0400410D0
(sv)
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
US20080287502A1
(en)
*
|
2004-03-30 |
2008-11-20 |
Dermatrends, Inc. |
Transdermal Administration of Proton Pump Inhibitors
|
ATE437869T1
(de)
|
2004-04-28 |
2009-08-15 |
Hetero Drugs Ltd |
Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050267157A1
(en)
*
|
2004-05-28 |
2005-12-01 |
David White |
Magnesium-S-omeprazole
|
US7365206B2
(en)
|
2004-05-28 |
2008-04-29 |
Hetero Drugs Limited |
Stereoselective synthesis of benzimidazole sulfoxides
|
MXPA06013623A
(es)
*
|
2004-06-02 |
2007-02-28 |
Altana Pharma Ag |
Procedimiento para la preparacion de compuestos piridin-2-ilmetilsulfinil-1h-benzimidazol.
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
EP2264025B1
(fr)
|
2004-09-13 |
2013-11-06 |
Takeda Pharmaceutical Company Limited |
Procédé de production de lansoprazole
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
EP2417986A1
(fr)
|
2004-11-22 |
2012-02-15 |
Anadis Ltd. |
Compositions bioactives
|
WO2006067599A2
(fr)
|
2004-12-23 |
2006-06-29 |
Ranbaxy Laboratories Limited |
Compositions orales stables de benzimidazoles et leur procede de preparation
|
US20080279951A1
(en)
*
|
2005-02-02 |
2008-11-13 |
Rajesh Gandhi |
Stable Oral Benzimidazole Compositions Prepared by Non-Aqueous Layering Process
|
EP1852100B1
(fr)
|
2005-02-25 |
2018-05-09 |
Takeda Pharmaceutical Company Limited |
Procédé de fabrication de granulés enrobés du benzimidazole
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
US7563812B2
(en)
|
2005-06-15 |
2009-07-21 |
Hetero Drugs Limited |
Amorphous esomeprazole hydrate
|
EP1898922A4
(fr)
*
|
2005-07-04 |
2012-03-14 |
Ramu Krishnan |
Medicament ou composes pharmaceutiques ameliores et preparation associee
|
WO2007008588A2
(fr)
*
|
2005-07-07 |
2007-01-18 |
Dr. Reddy's Laboratories Ltd. |
Omeprazole de forme b
|
TWI394750B
(zh)
*
|
2005-07-26 |
2013-05-01 |
Takeda Gmbh |
同位素取代之質子泵抑制劑
|
AR054583A1
(es)
*
|
2005-07-26 |
2007-06-27 |
Altana Pharma Ag |
Pantoprazol isotopicamente sustituido
|
US7601737B2
(en)
*
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
CA2624179A1
(fr)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Inhibiteurs deuteries d'atpase h+,k+ gastrique ayant des proprietes therapeutiques renforcees
|
US7576219B2
(en)
|
2005-10-26 |
2009-08-18 |
Hanmi Pharm. Co., Ltd |
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
|
WO2007067128A1
(fr)
|
2005-12-05 |
2007-06-14 |
Astrazeneca Ab |
Nouveau procede de fabrication d’esomeprazole sous forme non saline
|
EP1801110A1
(fr)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Sel d'arginine d'ésoméprazole
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
JP5053865B2
(ja)
|
2005-12-28 |
2012-10-24 |
武田薬品工業株式会社 |
口腔内崩壊性固形製剤の製造法
|
ATE428707T1
(de)
|
2005-12-28 |
2009-05-15 |
Union Quimico Farma |
Verfahren zur herstellung des (s)-enantiomers von omeprazol
|
EP2007360B1
(fr)
*
|
2006-04-03 |
2014-11-26 |
Isa Odidi |
Dispositif d'administration à libération commandée comprenant un enrobage organosol
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US7786309B2
(en)
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
JP5474541B2
(ja)
|
2006-07-25 |
2014-04-16 |
ベクタ・リミテッド |
小さいジカルボン酸の誘導体と組み合わせてppiを用いる胃酸分泌を阻害する組成物および方法
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
CA2665226C
(fr)
|
2006-10-05 |
2014-05-13 |
Santarus, Inc. |
Nouvelles formulations pour une liberation immediate d'inhibiteurs de pompe a protons et procedes d'utilisation de ces formulations
|
CA2667682A1
(fr)
|
2006-10-27 |
2008-05-15 |
The Curators Of The University Of Missouri |
Compositions comprenant des agents d'inhibition de la pompe a protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procedes d'utilisation
|
JP2010514702A
(ja)
|
2006-12-22 |
2010-05-06 |
アイロンウッド ファーマシューティカルズ,インコーポレーテッド |
食道障害の治療方法および治療用組成物
|
EP1947099A1
(fr)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Procédé pour l'élimination de solvant des sels d'oméprazole
|
EA200900985A1
(ru)
|
2007-01-31 |
2009-12-30 |
Крка, Товарна Здравил, Д. Д., Ново Место |
Способ получения оптически чистого омепразола
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
CA2678702A1
(fr)
|
2007-02-21 |
2008-08-28 |
Cipla Limited |
Procede pour la preparation de esomeprazole magnesium dihydrate
|
KR20090121388A
(ko)
*
|
2007-03-15 |
2009-11-25 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
신규 전구약물
|
EP2152691B1
(fr)
*
|
2007-06-07 |
2011-11-23 |
Aurobindo Pharma Limited |
Procédé amélioré pour préparer un inhibiteur de la pompe à protons optiquement actif
|
WO2009010937A1
(fr)
*
|
2007-07-17 |
2009-01-22 |
Ranbaxy Laboratories Limited |
Procédé de préparation de pantoprazole sodique.
|
WO2009066317A2
(fr)
*
|
2007-08-20 |
2009-05-28 |
Macleods Pharmaceuticals Limited |
Procédé de préparation de pantoprazole sodique
|
US8106210B2
(en)
|
2007-10-08 |
2012-01-31 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
CN101450939B
(zh)
*
|
2007-12-05 |
2013-06-19 |
沈阳药科大学 |
新型苯并咪唑类化合物
|
CA2716367C
(fr)
|
2008-02-20 |
2015-05-26 |
The Curators Of The University Of Missouri |
Composition comprenant une combinaison d'omeprazole et de lansoprazole, et un agent tampon, et ses methodes d'utilisation
|
US8911787B2
(en)
|
2008-02-26 |
2014-12-16 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
EP2278957A2
(fr)
*
|
2008-04-15 |
2011-02-02 |
Schering Corporation |
Compositions pharmaceutiques orales comprenant une dispersion solide contenant préférablement du posaconazole et un hpmcas
|
CN102065842A
(zh)
*
|
2008-04-15 |
2011-05-18 |
先灵公司 |
优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
|
KR101044880B1
(ko)
*
|
2008-06-12 |
2011-06-28 |
일양약품주식회사 |
항궤양제 화합물의 합성에 유용한 중간체의 제조방법
|
EP2147918A1
(fr)
|
2008-07-21 |
2010-01-27 |
LEK Pharmaceuticals D.D. |
Procédé de préparation de magnésium d'oméprazole S dans une forme stable
|
CH699302B1
(de)
*
|
2008-08-11 |
2012-03-15 |
Mepha Gmbh |
Orale pharmazeutische Formulierung für Omeprazol, enthaltend eine spezifische Trennschicht.
|
AU2009290712A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
WO2010042785A1
(fr)
*
|
2008-10-10 |
2010-04-15 |
Celtaxsys, Inc. |
Procédé d’induction d’un chimiotactisme négatif
|
EP2264024A1
(fr)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Procédé de préparation d'inhibiteurs de la pompe à protons énantiomériquement enrichis
|
WO2010134099A1
(fr)
|
2009-05-21 |
2010-11-25 |
Cadila Healthcare Limited |
Procédé de préparation dans un récipient unique d'oméprazole
|
DK2435825T3
(en)
|
2009-05-27 |
2015-10-19 |
Biotempus Ltd |
Modes for medical care
|
CN102638978A
(zh)
*
|
2009-06-25 |
2012-08-15 |
波曾公司 |
用于治疗需要阿司匹林治疗之患者的方法
|
EP2445499A4
(fr)
|
2009-06-25 |
2013-02-27 |
Astrazeneca Ab |
Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
|
WO2011058569A1
(fr)
|
2009-11-12 |
2011-05-19 |
Hetero Research Foundation |
Procédé de dédoublement de l'oméprazole
|
WO2011080502A2
(fr)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
|
EP2519229A2
(fr)
|
2009-12-29 |
2012-11-07 |
Novartis AG |
Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
|
WO2011080500A2
(fr)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
|
EP2345408A3
(fr)
|
2010-01-08 |
2012-02-29 |
Dr. Reddy's Laboratories Ltd. |
Formulations de médicament labiles acides
|
CN102140099A
(zh)
|
2010-02-02 |
2011-08-03 |
山东轩竹医药科技有限公司 |
新的吡啶衍生物
|
US9623622B2
(en)
|
2010-02-24 |
2017-04-18 |
Michael Baines |
Packaging materials and methods
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9233103B2
(en)
|
2011-03-25 |
2016-01-12 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
|
CN103826632B
(zh)
|
2011-08-26 |
2017-04-12 |
国立大学法人名古屋大学 |
骨形成促进剂及其用途
|
EA028342B1
(ru)
|
2011-09-09 |
2017-11-30 |
Мерк Шарп И Доум Корп. |
Способы лечения пневмонии
|
WO2013081566A1
(fr)
|
2011-11-25 |
2013-06-06 |
Mahmut Bilgic |
Formulation comprenant du benzimidazole
|
EP2601947A1
(fr)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori
|
UA115139C2
(uk)
|
2011-12-28 |
2017-09-25 |
Поузен Інк. |
Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
|
CN102584792B
(zh)
*
|
2012-01-06 |
2014-06-11 |
南京优科生物医药研究有限公司 |
制备高纯度的埃索美拉唑盐的方法
|
WO2013108068A1
(fr)
|
2012-01-21 |
2013-07-25 |
Jubilant Life Sciences Limited |
Procédé de préparation de 2-pyridinylméthylsulfinylbenzimidazoles, leurs analogues et énantiomères optiquement actifs
|
US8809314B1
(en)
|
2012-09-07 |
2014-08-19 |
Cubist Pharmacueticals, Inc. |
Cephalosporin compound
|
US8476425B1
(en)
|
2012-09-27 |
2013-07-02 |
Cubist Pharmaceuticals, Inc. |
Tazobactam arginine compositions
|
CN105338958A
(zh)
|
2013-01-15 |
2016-02-17 |
铁木医药有限公司 |
胆汁酸螯合剂的胃内滞留缓释口服剂型
|
US9872906B2
(en)
|
2013-03-15 |
2018-01-23 |
Merck Sharp & Dohme Corp. |
Ceftolozane antibiotic compositions
|
NZ700372A
(en)
|
2013-03-15 |
2016-01-29 |
Merck Sharp & Dohme |
Ceftolozane antibiotic compositions
|
US20140274997A1
(en)
|
2013-03-15 |
2014-09-18 |
Cubist Pharmaceuticals, Inc. |
Cephalosporin pharmaceutical compositions
|
GB201306720D0
(en)
|
2013-04-12 |
2013-05-29 |
Special Products Ltd |
Formulation
|
EP3043797B1
(fr)
|
2013-09-09 |
2020-04-08 |
Merck Sharp & Dohme Corp. |
Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
|
US8906898B1
(en)
|
2013-09-27 |
2014-12-09 |
Calixa Therapeutics, Inc. |
Solid forms of ceftolozane
|
US9457011B2
(en)
|
2014-02-25 |
2016-10-04 |
Muslim D. Shahid |
Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor
|
FR3018812A1
(fr)
|
2014-03-21 |
2015-09-25 |
Minakem |
Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
|
WO2015155307A1
(fr)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Combinaisons pharmaceutiques de rivaroxaban et d'inhibiteurs de pompe à protons
|
EP2933002A1
(fr)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Compositions pharmaceutiques comprenants de dabigratan et des inhibiteurs de la pompe à protons
|
CN104045627A
(zh)
*
|
2014-05-21 |
2014-09-17 |
丽珠医药集团股份有限公司 |
一种奥美拉唑纯化方法
|
US10548911B2
(en)
|
2014-06-16 |
2020-02-04 |
University Of Rochester |
Small molecule anti-scarring agents
|
WO2016126625A1
(fr)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Méthodes de traitement de troubles gastro-intestinaux supérieurs de gerd réfractaire à ppi
|
EP3288556A4
(fr)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Compositions à désintégration par voie orale
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
EP3496714A4
(fr)
*
|
2016-08-11 |
2020-04-22 |
Adamis Pharmaceuticals Corporation |
Compositions de médicaments.
|
EP3292862A1
(fr)
|
2016-09-07 |
2018-03-14 |
Sandoz Ag |
Formulations d'oméprazole
|
CA3036250C
(fr)
*
|
2016-09-14 |
2023-09-26 |
Yufeng Jane Tseng |
Nouveaux derives de benzimidazole substitues utilises en tant qu'inhibiteurs de la d-amino-acide oxydase (daao)
|
WO2019113493A1
(fr)
|
2017-12-08 |
2019-06-13 |
Adamis Pharmaceuticals Corporation |
Compositions de médicaments
|
CN110317164B
(zh)
*
|
2019-07-06 |
2022-08-19 |
抚州三和医药化工有限公司 |
一种奥美拉唑中间体的制备方法
|
US20220257597A1
(en)
|
2021-01-29 |
2022-08-18 |
Abbvie Inc. |
Methods of Administering Elagolix
|
WO2024075017A1
(fr)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition de calcification de valve aortique
|